InsidersTradesSigma
Follow the Arctic Bioscience AS stock price and the full insider trade history of the company, a listed issuer based in Norway. Shares are quoted on the NO market, under the oversight of Oslo Børs. Operating in the Health Care sector, Arctic Bioscience AS has published 56 insider filings. Market capitalisation: €77.4m. The latest transaction was filed on 1 April 2026 (Sale). Among the most active insiders: Jone R. Slinning. All data is free.
56
Insider Decl.
n/a
Thresholds
€870,814
39 ops.
Buy Volume
€5m
9 ops.
Sell Volume
22Σ signal
Fundamental score
Ranked 27,847 of 29,063 companies
14.7
score / 100
Value3
Quality26
FCF yld-60%
Earn yld-54%
EV/EBITDA·
ROE-21%
Gross mgn28%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 April 2026
Declarations56 total
MERKOSLO:669931
MERKOSLO:669930
MERKOSLO:636419
MERKOSLO:636418
10,000 shares@ NOK 1.720.2% of flowShareMERKOSLO:630017
10,000 sharesShareMERKOSLO:630016
520,240 shares@ NOK 2.23100.0% of flowShareMERKOSLO:629927
520,240 sharesShareMERKOSLO:629926
2,000 sharesShareMERKOSLO:629908
2,000 shares@ NOK 2.400.9% of flowShareMERKOSLO:629907
20,000 sharesShareMERKOSLO:629884
20,000 shares@ NOK 2.32100.0% of flowShareMERKOSLO:629883
5,000 shares@ NOK 2.50100.0% of flowShareMERKOSLO:629781
5,000 sharesShareMERKOSLO:629780
10,000 shares@ NOK 2.869.0% of flowShareMERKOSLO:629721
10,000 sharesShareMERKOSLO:629720
5,000 shares@ NOK 3.000.0% of flowShareMERKOSLO:629710
5,000 sharesShareMERKOSLO:629709
5,000 shares@ NOK 3.080.0% of flowShareMERKOSLO:629675
5,000 sharesShareMERKOSLO:629674
ShareMERKOSLO:628242
3,087,999 shares@ NOK 13.50100.0% of flowShareMERKOSLO:628241
10 shares@ NOK 10.420.0% of flowShareMERKOSLO:624132
10,000 sharesShareMERKOSLO:624131
4 shares@ NOK 10.50100.0% of flowShareMERKOSLO:622957
25 of 56 declarations
关于 Arctic Bioscience AS
Arctic Bioscience AS 是一家专注于健康和制药领域的公司，致力于开发创新的人类健康解决方案。该公司在 XOSL 市场上市。
